| Age (years), Mean (SD) |
65.8 (9) |
75.5 (9) |
| Sex (Male) |
625 (52.2%) |
155 (73.5%) |
| BMI (kg/m2), Mean (SD) |
28.3 (5) |
28.8 (5) |
| sTNF-R1 (pg/mL), Median (IQR) |
1175.9 (362) |
1514.0 (749) |
| IL-6 (pg/mL), Median (IQR) |
2.3 (3) |
3.6 (3) |
| hsCRP (mg/L), Median (IQR) |
1.7 (2) |
2.2 (4) |
| eGFR (mL/min/1.73 m2), Mean (SD) |
86.3 (21) |
75.6 (27) |
| Low-density lipoprotein (LDL) (mmol/l), Mean (SD) |
3.4 (1) |
3.2 (1) |
| High-density lipoprotein (HDL) (mmol/l), Mean (SD) |
1.4 (0) |
1.3 (0) |
| Total cholesterol (mmol/l), Mean (SD) |
5.5 (1) |
5.3 (1) |
| Triglycerides (mmol/l), Mean (SD) |
1.9 (1) |
2.0 (1) |
| Sport Index, Mean (SD) |
2.5 (0.8) |
2.3 (0.7) |
| Prevalence of |
|
|
| Chronic Heart Failure |
92 (7.7%) |
53 (2.5%) |
| Myocardial Infarction |
67 (5.6%) |
32 (15.2%) |
| Stroke |
40 (3.3%) |
26 (12.3%) |
| Hypertension |
911 (76.1%) |
193 (91.5%) |
| Diabetes Mellitus Type 2 |
186 (15.5%) |
64 (30.3%) |
| Rheumatism |
113 (9.4%) |
22 (10.4%) |
| Cancer |
106 (8.9%) |
44 (20.9%) |
| Thyroid Disease |
315 (26.3%) |
58 (27.5%) |
| Thyroid Medication |
227 (19%) |
37 (17.5%) |
| Lipids/ Statins Medication |
272 (22.7%) |
67 (31.8%) |
| Antihypertensive Medication |
731 (61.1%) |
174 (82.5%) |
| Antiplatelet Medication |
232 (19.4%) |
72 (34.1%) |
| Smoking |
Never |
545 (45.5%) |
62 (29.4%) |
| Current |
166 (13.9%) |
23 (10.9%) |
| Occasional |
27 (2.3%) |
4 (1.9%) |
|
Ex-Smoker |
455 (38.0%) |
119 (56.4%) |
